Transgender Assistant Secretary for Health for the Department of Health and Human Services (HHS) Rachel Levine recently praised the work of children’s hospitals, such as Connecticut Children’s Medical Center (CCMC) in Hartford, for their “gender-affirming care” clinics that provide children and teens with puberty blockers, cross-sex hormones, and transgender surgeries, such as elective double mastectomies.
Levine (born Richard Levine) told a very welcoming audience at CCMC’s Pediatric Grand Rounds in February that “lesbian, gay, bisexual, transgender, queer and intersex Americans, especially our youth … need our attention because they’re being attacked and … are attempting suicide at an alarming rate.”
More doctors are publicly condemning the Marxist racial and gender ideological agenda into which medical school students are being trained, asserting patents’ health, and even their lives, are being sacrificed for a totalitarian political worldview.
A report published last week, for example, by Do No Harm, an organization of physicians, healthcare professionals, medical students, patients, and policymakers, revealed the pervasive infiltration of woke diversity, equity, and inclusion (DEI) ideologies in Tennessee medical school curricula and programs.
A Biden administration top health official who identifies as transgender and has encouraged parents and doctors to use puberty blockers and cross-sex hormones to immediately “affirm” a child’s preferred “gender identity,” said during a public event he has “no regrets” that his “transition” took over ten years because he “can’t imagine a life without my children.”
As a headline at The Washington Stand noted, Dr. Rachel (born Richard) Levine appears to have admitted that “gender transition procedures can cause sterility.”
Health insurance claims data for treatment of gender dysphoria in children aged 6-17 years shows puberty blocker prescriptions have doubled since 2017, and claims for cross-sex hormones also doubled up until 2021.
According to data compiled by Komodo Health Inc for Reuters in October, in 2021, 42,167 children and teens between the ages of 6 and 17 were diagnosed with gender dysphoria, three times the number in 2017.
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) may have scheduled in its meeting agenda for Wednesday and Thursday a vote on whether to recommend adding COVID-19 shots to the standard Child and Adolescent Immunization Schedule.
The agenda’s wording is ambiguous, as Children’s Health Defense (CHD) President and General Counsel Mary Holland noted.
Various medical boards, and now even a California bill, threaten doctors who have exercised their independence from the government’s narrative in their efforts to discuss the risks of the COVID mRNA shots and the benefits of early treatments for COVID-19 with their patients.
Certification boards such as the American Board of Internal Medicine (ABIM), the American Board of Obstetrics & Gynecology (ABOG), and the American Board of Family Medicine (ABFM) have all been named in a federal lawsuit filed in July by the Association of American Physicians and Surgeons Educational Foundation (AAPS) in U.S. District Court for the Southern District of Texas.
The World Health Organization (WHO) has updated its 2011 manual titled Gender Mainstreaming for Health Managers: A Practical Approach, to include new guidance that now claims “sex is not limited to male or female.”
In a press release two weeks ago, the global health agency of the United Nations (UN) said it would now be recognizing “that gender inequality is a cross-cutting determinant of health that operates in conjunction with other forms of discrimination based on factors such as age, socioeconomic status, ethnicity or place of origin and sexual orientation.”
The Food and Drug Administration (FDA) quickly authorized the Moderna and Pfizer-BioNTech COVID vaccine shots for infants and young children Friday, paving the way for the Centers for Disease Control and Prevention (CDC) advisory committee to vote on authorization over the weekend to allow the youngest children to get the shots as early as next week.
Per the press announcement by the FDA, the Emergency Use Authorization (EUA) for the Moderna COVID vaccine for older children and adults has been “amended” to “include use of the vaccine in individuals 6 months through 17 years of age,” while the EUA for the Pfizer COVID shot will now include use of the vaccine for babies as young as “6 months through 4 years of age.”
The Food and Drug Administration’s (FDA) vaccine advisory panel unanimously voted Wednesday to recommend the Moderna and Pfizer vaccines for infants and young children despite an abundance of calls from physicians, children’s health organizations, and members of Congress to refrain from approving the shots for a population that shows the least risk for serious disease from COVID.
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted, 21-0, in favor of recommending Emergency Use Authorization (EUA) for the Moderna and Pfizer mRNA COVID vaccines for infants, toddlers, and preschool-age children.